China’s Experimental COVID-19 Vaccine Appears Safe In Early Trials: Study

0
12
China has at least 4 experimental vaccines in the final stage of clinical trials. (Representational)
In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group’s experimental shot showed no severe adverse reactions, its researchers said.

LEAVE A REPLY

Please enter your comment!
Please enter your name here